DEF: Syra Health Sets 2025 Annual Meeting Agenda, Proposes Class B Stock Changes

Syra Health Corp. announced its 2025 Annual Meeting of Stockholders to elect directors, ratify auditors, and vote on amendments to Class B Common Stock conversion and transfer rules.

Summary

• The Annual Meeting of Stockholders is scheduled for November 14, 2025, at 9:00 a.m. Eastern Standard Time, at the company's offices in Carmel, IN.
• Stockholders will vote on four proposals: electing five members to the Board of Directors, ratifying M&K CPAS, PLLC as the independent registered public accounting firm for fiscal year 2025, and approving two amendments related to Class B Common Stock.
• The first proposed amendment seeks to delete Article IV, Section 4.2.8(D) of the Amended and Restated Certificate of Incorporation, which currently mandates the automatic conversion of Class B Common Stock upon the death of a Class B stockholder.
• The second proposed amendment aims to add immediate family members, heirs, successors, and assigns as parties to whom Class B stockholders can transfer shares without triggering automatic conversion to Class A Common Stock.
• As of the record date, September 17, 2025, there were 11,339,169 shares of Class A common stock outstanding (one vote per share) and 600,000 shares of Class B common stock outstanding (16.5 votes per share).
• Deepika Vuppalanchi, the former Chief Executive Officer, was terminated for cause on July 28, 2025, and Sandeep Allam, the former President and Chairman, passed away on January 15, 2025.
• Priya Prasad, the Chief Financial Officer, was appointed Interim Chief Executive Officer in June 2025, with a monthly compensation of $6,100 for this interim role.
• The company disclosed several related party transactions with entities beneficially owned by principal owners and management, including advances from Sahasra Technologies Corp., lease payments to STVentures, LLC, IT services from RAD CUBE LLC, and recruitment services from NLogix.

Sentiment

Score: 5

Explanation: The filing is a routine proxy statement for an annual meeting, presenting standard corporate governance proposals. While it discloses significant management changes (CEO termination, President's death) and ongoing related party transactions, these are presented as factual updates rather than new, unexpected developments impacting immediate financial performance. The proposed amendments to Class B Common Stock aim to provide flexibility, which is neutral to slightly positive for Class B holders but could be viewed neutrally to slightly negatively by Class A holders due to potential perpetuation of concentrated voting power. The overall tone is informative and procedural, without strong positive or negative financial implications.

Positives

• The Board of Directors is committed to good corporate governance practices, including a Code of Business Conduct and Ethics, insider trading policy, and anti-hedging policy.
• Three of the five incumbent directors (Dr. Vijayapal Reddy, Dr. Ketan Paranjape, and Dr. Avutu Reddy) are determined to be independent, meeting Nasdaq and SEC independence requirements.
• The proposed amendments to Class B Common Stock aim to provide greater flexibility and control for Class B stockholders in succession planning and estate administration, aligning with current market practices.
• The company has established an Audit Committee, Compensation Committee, and Nominating and Governance Committee with defined responsibilities for risk oversight and corporate governance.

Negatives

• The termination of former CEO, Deepika Vuppalanchi, for cause on July 28, 2025, indicates potential internal issues or performance concerns.
• The passing of former President and Chairman, Sandeep Allam, on January 15, 2025, represents a significant loss of leadership and experience.
• Priya Prasad, the current Interim CEO and CFO, failed to report one transaction on time on a Form 4, indicating a minor compliance lapse.
• Significant related party transactions with entities beneficially owned by principal owners and management, totaling over $1.9 million in 2024, raise potential conflict of interest concerns, despite a policy for review.
• The Nominating and Governance Committee held zero meetings in fiscal year 2024, which could suggest a lack of active oversight in director nominations and governance principles during that period.
• The dual-class share structure, where Class B shares carry 16.5 votes per share compared to Class A's one vote, concentrates significant voting power among a few individuals, potentially limiting the influence of Class A shareholders.

Risks

• The proposed amendments to Class B Common Stock, by preserving its status upon death or transfer to family/heirs, could perpetuate a concentrated voting structure, potentially affecting voting dynamics and long-term stockholder composition.
• Reliance on related parties for significant services (e.g., recruitment, IT, office lease) could pose risks regarding arm's-length pricing, potential conflicts of interest, and the company's ability to secure more favorable terms from independent third parties.
• Changes in key management, including the termination of the CEO and the death of the President, introduce leadership transition risks that could impact strategic direction and operational stability.
• The company's Class A common stock is listed on the OTCQB, having previously been listed on the Nasdaq Capital Market, which may indicate a delisting or move to a less liquid market, potentially affecting investor confidence and share price volatility.

Future Outlook

The filing primarily focuses on corporate governance matters for the upcoming Annual Meeting and does not provide specific forward-looking financial guidance or strategic outlook beyond the proposed amendments to the Certificate of Incorporation.

Management Comments

• We are pleased to invite you to attend the annual meeting of stockholders.
• Your vote is very important.
• We are pleased to take advantage of the SEC rule that allows companies to furnish their proxy materials over the Internet.
• The Board knows of no other matters that will be presented for consideration at the Annual Meeting.
• We believe that Ms. Prasad is qualified to serve as a member of the Company's board of directors because of her experience as an executive of the Company and senior leadership roles.
• We believe that Dr. Reddy is qualified to serve as a member of the Company's board of directors because of his medical and scientific background and experience in scientific research.
• We believe that Dr. Paranjape is qualified to serve as a member of the Company's board of directors because of his engineering and commercial background and experience in advisory roles, technology and product development.
• We believe that Dr. Reddy is qualified to serve as a member of the Company's board of directors because of his academic background and diverse experience in a multinational company.
• We believe that Ms. Mereddy is qualified to serve as a member of the Company's board of directors because of her extensive experience in information systems and business process improvement, leveraging technology and information to make organizations faster, smarter, and more reliable.
• The Board of Directors believes that open communication between management and the Board of Directors is essential for effective risk management and oversight.
• We intend to use the 2022 Plan to provide incentives that will enable us to attract, retain, and motivate employees, officers, consultants, and directors.

Industry Context

This filing is a standard proxy statement, primarily addressing internal corporate governance, board elections, and amendments to the company's charter. It does not contain information that directly relates to broader industry trends or competitive landscape analysis. The proposed changes to Class B Common Stock structure are internal governance matters, not industry-specific.

Comparison to Industry Standards

• The governance practices, such as having independent directors and established committees (Audit, Compensation, Nominating & Governance), align with general industry standards for publicly traded companies.
• The dual-class share structure with Class B shares having 16.5 votes per share deviates from the 'one share, one vote' principle often favored by institutional investors and is less common, though not unheard of, in the broader market.
• The significant volume of related party transactions, while disclosed and subject to a policy, is higher than typically observed in companies striving for strict arm's-length dealings, potentially raising questions about best practices in corporate transparency and independence.

Management Changes

Corporate Governance

Related Party Transactions

• Sahasra Technologies Corp. (STLogics), an entity beneficially owned by the principal owners and management, made $1,295,010 in short-term, non-interest bearing advances to Syra in 2023. Syra repaid $1,095,000 and offset $200,010 with payroll costs, resulting in a $50,614 receivable from STLogics as of December 31, 2023.
• Syra leases its corporate headquarters from STVentures, LLC, an entity whose members include former President Sandeep Allam, Feroz Syed, and HariKrishna Allam (husband of Interim CEO Priya Prasad). Rent expenses were $131,516 in 2024 and $128,527 in 2023.
• RAD CUBE LLC, beneficially owned by principal owners and management (including Sandeep Allam, Feroz Syed, and Priya Prasad), provided outsourced IT services to Syra, incurring expenses of $22,233 in 2024 and $3,320 in 2023.
• NLogix, partially owned by former President Sandeep Allam and Feroz Syed, provided recruitment and human resource services to Syra, with expenses totaling $516,129 in 2024 and $348,304 in 2023.

Stakeholder Impact

• Shareholders (Class B): Will benefit from increased flexibility in transferring Class B shares to immediate family members, heirs, successors, and assigns without automatic conversion, preserving their higher voting power and facilitating estate planning.
• Shareholders (Class A): May experience a continued concentration of voting power in Class B holders, potentially limiting their influence on corporate decisions and governance.
• Management/Directors: The proposed amendments provide more control over the succession and transfer of Class B shares, which are largely held by current and former management/principal owners.
• Employees: The company continues to offer broad-based employee benefit programs, including a 401(k) plan with matching contributions, which supports employee welfare and retention.
• Creditors/Suppliers: No direct impact is explicitly mentioned, but the ongoing and significant related party transactions could be a factor in assessing the company's financial transparency and the arm's-length nature of its dealings.

Next Steps

• Stockholders are to vote on five (5) director nominees at the Annual Meeting on November 14, 2025.
• Stockholders are to vote on the ratification of M&K CPAS, PLLC as the independent registered public accounting firm for fiscal year 2025.
• Stockholders are to vote on an amendment to delete Article IV, Section 4.2.8(D) regarding automatic conversion of Class B Common Stock upon death.
• Stockholders are to vote on an amendment to Section 4.2.8 to permit transfers of Class B Common Stock to immediate family members, heirs, successors, and assigns without automatic conversion.
• The Board of Directors will file a Current Report on Form 8-K with the SEC within four business days after the Annual Meeting to disclose preliminary or final voting results.
• Stockholders interested in submitting proposals for the 2026 Annual Meeting must adhere to specific deadlines: May 22, 2026, for Rule 14a-8 proposals; between July 17, 2026, and August 16, 2026, for bylaws proposals; and no later than September 14, 2026, for Rule 14a-19 director nominees.

Key Dates

Recommendation

The filing is a standard proxy statement for an annual meeting, primarily focused on corporate governance matters, director elections, and proposed amendments to the company's Certificate of Incorporation. It does not contain new financial results or strategic announcements that would warrant a 'buy' or 'sell' recommendation. While there are notable management changes (CEO termination, President's death) and ongoing related party transactions, these are disclosures of past events or existing arrangements. The proposed changes to Class B Common Stock aim to provide flexibility for existing holders but do not fundamentally alter the company's operational or financial prospects. Given the routine nature of the filing and the absence of new material financial or operational information, a 'hold' recommendation is appropriate for existing investors to maintain their current position while awaiting further substantive updates on the company's performance and strategy.

Keywords

Syra Health Corp, SEC filing, proxy statement, corporate governance, board of directors, Class B Common Stock, stockholder meeting, executive compensation, related party transactions, auditor ratification, management changes, equity incentive plan, voting rights, dual-class shares, SYRA